Reumatología

2020

1. 2018 updated European League against Rheumatism evidence-based recommendations for the diagnosis of gout

   Annals of the Rheumatic Diseases, Vol. 79, Núm. 1, pp. 31-38

2. Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients

   Rheumatology (Oxford, England), Vol. 59, Núm. 12, pp. 3906-3916

3. Anti-IL-6 therapy reduces leptin serum levels in patients with rheumatoid arthritis

   Clinical and experimental rheumatology, Vol. 38, Núm. 6, pp. 1201-1205

4. Anti-il-6 receptor tocilizumab in refractory graves’ orbitopathy: National multicenter observational study of 48 patients

   Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-15

5. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality

   Lupus, Vol. 29, Núm. 12, pp. 1556-1565

6. Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).

   Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 657-662

7. Bacteremia in systemic lupus erythematosus in patients from a Spanish registry: Risk factors, clinical and microbiological characteristics, and outcomes

   Journal of Rheumatology, Vol. 47, Núm. 2, pp. 234-240

8. Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients

   Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 608-615

9. Carotid plaques as predictors of cardiovascular events in patients with Rheumatoid Arthritis. Results from a 5-year-prospective follow-up study

   Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 6, pp. 1333-1338

10. Clinically significant renal involvement in primary Sjögren's syndrome is associated with important morbidity: data from the Spanish Sjögrenser cohort

    Clinical and experimental rheumatology, Vol. 38, Núm. 4, pp. 116-124

11. Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 5, pp. 897-901

12. Current laboratory and clinical practices in reporting and interpreting anti-nuclear antibody indirect immunofluorescence (ANA IIF) patterns: results of an international survey

    Autoimmunity Highlights, Vol. 11, Núm. 1

13. Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology

    Reumatologia Clinica, Vol. 16, Núm. 5, pp. 373-377

14. Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)

    Lupus, Vol. 29, Núm. 1, pp. 27-36

15. Digestive involvement in primary Sjögren's syndrome: analysis from the Sjögrenser registry

    Clinical and experimental rheumatology, Vol. 38, Núm. 4, pp. 110-115

16. Disease features associated with a low disease impact in patients with psoriatic arthritis: Results of a cross-sectional multicenter study

    Arthritis Research and Therapy, Vol. 22, Núm. 1

17. Efficacy and Safety of Combined Therapy With Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Systematic Literature Review

    Reumatologia Clinica, Vol. 16, Núm. 5P1, pp. 324-332

18. Efficacy and safety of glucocorticoids in rheumatoid arthritis: Systematic literature review

    Reumatologia Clinica, Vol. 16, Núm. 3, pp. 222-228

19. Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools

    Clinical and experimental rheumatology, Vol. 38, Núm. 6, pp. 1056-1067

20. Expert Recommendations on the Interleukin 6 Blockade in Patients with Rheumatoid Arthritis

    Reumatologia Clinica, Vol. 16, Núm. 4, pp. 272-281